| Primary |
| Anaesthesia |
16.3% |
| Induction Of Anaesthesia |
14.2% |
| General Anaesthesia |
10.6% |
| Endotracheal Intubation |
9.9% |
| Tumour Excision |
7.8% |
| Hospitalisation |
5.0% |
| Analgesic Therapy |
4.3% |
| Muscle Relaxant Therapy |
4.3% |
| Premedication |
4.3% |
| Chronic Lymphocytic Leukaemia |
3.5% |
| Electroconvulsive Therapy |
2.8% |
| Maintenance Of Anaesthesia |
2.8% |
| Intubation |
2.1% |
| Neuromuscular Blockade |
2.1% |
| Product Used For Unknown Indication |
2.1% |
| Surgery |
2.1% |
| Anaesthesia Procedure |
1.4% |
| Depression |
1.4% |
| Paranoia |
1.4% |
| Preoperative Care |
1.4% |
|
| Pyrexia |
10.9% |
| Ventricular Tachycardia |
10.9% |
| Drug Ineffective |
9.1% |
| Post Procedural Complication |
9.1% |
| Ventricular Fibrillation |
9.1% |
| Cardiac Arrest |
5.5% |
| Postoperative Fever |
5.5% |
| Apnoea |
3.6% |
| Medication Error |
3.6% |
| Muscle Rigidity |
3.6% |
| Pharmaceutical Product Complaint |
3.6% |
| Pneumonia Aspiration |
3.6% |
| Pseudocholinesterase Deficiency |
3.6% |
| Rash Macular |
3.6% |
| Rhabdomyolysis |
3.6% |
| Ventricular Tachyarrhythmia |
3.6% |
| Amyotrophic Lateral Sclerosis |
1.8% |
| Anaphylactic Reaction |
1.8% |
| Blood Cholinesterase Decreased |
1.8% |
| Blood Creatinine Increased |
1.8% |
|
| Secondary |
| Anaesthesia |
26.5% |
| Induction Of Anaesthesia |
14.7% |
| Drug Use For Unknown Indication |
12.9% |
| Product Used For Unknown Indication |
12.1% |
| General Anaesthesia |
11.4% |
| Premedication |
6.2% |
| Analgesic Therapy |
1.9% |
| Endotracheal Intubation |
1.6% |
| Caesarean Section |
1.4% |
| Maintenance Of Anaesthesia |
1.4% |
| Antiphospholipid Syndrome |
1.3% |
| Prophylaxis |
1.3% |
| Antibiotic Prophylaxis |
1.0% |
| Sedation |
1.0% |
| Anaesthesia Procedure |
0.9% |
| Analgesia |
0.9% |
| Hypotonia |
0.9% |
| Prophylaxis Of Nausea And Vomiting |
0.9% |
| Completed Suicide |
0.8% |
| Induction And Maintenance Of Anaesthesia |
0.8% |
|
| Anaphylactic Shock |
19.1% |
| Cardiac Arrest |
12.2% |
| Ventricular Tachycardia |
9.6% |
| Anaphylactic Reaction |
6.1% |
| Bronchospasm |
5.2% |
| Death |
5.2% |
| Torsade De Pointes |
4.3% |
| Erythema |
3.5% |
| Maternal Exposure During Pregnancy |
3.5% |
| Rhabdomyolysis |
3.5% |
| Somatoform Disorder |
3.5% |
| Tachycardia |
3.5% |
| Bradycardia |
2.6% |
| Circulatory Collapse |
2.6% |
| Drug Exposure During Pregnancy |
2.6% |
| Premature Baby |
2.6% |
| Premature Rupture Of Membranes |
2.6% |
| Shock |
2.6% |
| Sinus Bradycardia |
2.6% |
| Somnolence |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.6% |
| Drug Use For Unknown Indication |
14.8% |
| Coronary Artery Bypass |
7.7% |
| Anaesthesia |
3.8% |
| Induction Of Anaesthesia |
3.6% |
| General Anaesthesia |
3.0% |
| Maintenance Of Anaesthesia |
2.4% |
| Pain |
2.2% |
| Sedation |
2.2% |
| Aortic Valve Replacement |
2.1% |
| Catheterisation Cardiac |
1.6% |
| Mitral Valve Replacement |
1.4% |
| Anxiety |
1.3% |
| Prophylaxis |
1.3% |
| Mitral Valve Repair |
1.3% |
| Chronic Lymphocytic Leukaemia |
1.1% |
| Hypertension |
1.0% |
| Traumatic Haemorrhage |
1.0% |
| Prostate Cancer |
0.8% |
| Depression |
0.7% |
|
| Pain |
10.1% |
| Anhedonia |
8.6% |
| Unevaluable Event |
8.6% |
| Injury |
8.1% |
| Renal Failure |
7.6% |
| Anxiety |
6.1% |
| Emotional Distress |
5.6% |
| Stress |
5.6% |
| Renal Impairment |
5.1% |
| Respiratory Failure |
5.1% |
| Vomiting |
5.1% |
| Fear |
4.5% |
| Myoclonus |
3.0% |
| Shock Haemorrhagic |
3.0% |
| Pulmonary Embolism |
2.5% |
| Renal Injury |
2.5% |
| Sepsis |
2.5% |
| Unresponsive To Stimuli |
2.5% |
| Anaphylactic Reaction |
2.0% |
| Death |
2.0% |
|
| Interacting |
| Product Used For Unknown Indication |
33.3% |
| Chronic Lymphocytic Leukaemia |
27.3% |
| Anaesthesia |
15.2% |
| General Anaesthesia |
12.1% |
| Hypertension |
6.1% |
| Induction Of Anaesthesia |
3.0% |
| Skin Wrinkling |
3.0% |
|
| Apnoea |
57.1% |
| Drug Interaction |
28.6% |
| Pregnancy |
14.3% |
|
